Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Rockwell Medical Inc. RMTI

Rockwell Medical is a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney. Rockwell is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States. The Company is dedicated to providing the hemodialysis community with the highest quality... see more

Recent & Breaking News (NDAQ:RMTI)

Rockwell Medical Announces Long-Term, National Supply Agreement With DaVita

Globe Newswire May 8, 2013

Rockwell Medical Reports 2013 First Quarter Results; Signs Long-Term, National Supply Agreement With DaVita

Globe Newswire May 8, 2013

Rockwell Medical to Present ESA-Sparing PRIME Study Data at 50th ERA-EDTA Congress, Istanbul 2013

Marketwired May 6, 2013

Rockwell Medical Submits Calcitriol Manufacturing Data to FDA for Approval

Marketwired April 1, 2013

Rockwell Medical Closes $12.9 Million Registered Direct Common Stock Offering

Globe Newswire March 26, 2013

Rockwell Medical to Raise $12.9 Million in Registered Direct Common Stock Offering

Troy Schwensen March 20, 2013

Rockwell Medical Reports 2012 Fourth Quarter and Full Year Results

Troy Schwensen March 18, 2013

Rockwell Medical Schedules Conference Call Reporting Fourth Quarter and 2012 Year End Results

Troy Schwensen March 7, 2013

Rockwell Medical Announces Iron Delivery Drug SFP Meets Primary Endpoint in PRIME Clinical Study Demonstrating Statistically Significant 37% Reduction in ESA Dose

PR Newswire February 4, 2013

Rockwell Medical Appoints Professor Francesco Locatelli, MD, FRCPB to Its Scientific Advisory Board

Marketwired January 14, 2013

Rockwell Medical Announces Final Patient Dosed in PRIME Clinical Study

Marketwired January 7, 2013